Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial
ESCUDIER, B, MICHAELSON, M. D, TARAZI, J, ROSBROOK, B, CISAR, L, HARIHARAN, S, KIM, S, RINI, B. I, MOTZER, R. J, HUTSON, T. E, CLARK, J. I, LIM, H. Y, PORFIRI, E, ZALEWSKI, P, KANNOURAKIS, G, STAEHLER, M
Published in British journal of cancer (10.06.2014)
Published in British journal of cancer (10.06.2014)
Get full text
Journal Article
Metastatic clear cell renal cell carcinoma patients with ECOG performance status 2 treated with pazopanib: The Pazo2 trial of efficacy and safety
Porfiri, E., Pirrie, S., Hodgkins, A.-M., Farrugia, D., Fife, K., McDonald-Smith, C., Vasudev, N.S., Nixon, G., James, N.D., Stubbs, C.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
2604 Liver toxicity associated with the use of Pazopanib in renal cancer patients: UK teaching hospital experience
Jain, A, Canipari, C, Haque, F, Solanki, H, Kumar, A, Porfiri, E
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
The effects and effectiveness of electromotive drug administration and chemohyperthermia for treating non-muscle invasive bladder cancer
Slater, S E, Patel, P, Viney, R, Foster, M, Porfiri, E, James, N D, Montgomery, B, Bryan, R T
Published in Annals of the Royal College of Surgeons of England (01.09.2014)
Published in Annals of the Royal College of Surgeons of England (01.09.2014)
Get full text
Journal Article
Initial feasibility and safety results from a phase II/III clinical trial to evaluate docetaxel (D) therapy in combination with zoledronic acid (ZA) ± strontium-89 (Sr89) in hormone-refractory prostate cancer patients: ISRCTN12808747
Porfiri, E., Collins, S. I., Barton, D., Billingham, L., McLaren, D., Nixon, G. G., Russell, J. M., Parker, C., Wylie, J., James, N. D.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Prenylation of Ras proteins is required for efficient hSOS1-promoted guanine nucleotide exchange
Porfiri, E, Evans, T, Chardin, P, Hancock, J F
Published in The Journal of biological chemistry (09.09.1994)
Published in The Journal of biological chemistry (09.09.1994)
Get full text
Journal Article
Effect of the UK Postcode Lottery on Survival of Patients with Metastatic Renal Cancer: an Audit of Outcomes in Patients with Metastatic Renal Cancer Suitable for Treatment with Tyrosine Kinase Inhibitors
James, N, Pascoe, J, Zachariah, A, Ray, D, Oldroyd, A, Parry, H, Benghiat, H, Karina, M, Collins, S, Porfiri, E
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.10.2009)
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.10.2009)
Get full text
Journal Article
Loss of hMLH1 expression correlates with improved survival in stage III–IV ovarian cancer patients
Scartozzi, M, De Nictolis, M, Galizia, E, Carassai, P, Bianchi, F, Berardi, R, Gesuita, R, Piga, A, Cellerino, R, Porfiri, E
Published in European journal of cancer (1990) (01.05.2003)
Published in European journal of cancer (1990) (01.05.2003)
Get full text
Journal Article
Effectiveness of the crcapro program in identifying patients suspected for HNPCC
Bianchi, F, Galizia, E, Bracci, R, Belvederesi, L, Catalani, R, Loretelli, C, Giorgetti, G, Ferretti, C, Bearzi, I, Porfiri, E, Cellerino, R
Published in Clinical genetics (01.02.2007)
Published in Clinical genetics (01.02.2007)
Get full text
Journal Article
MSH2 splice site mutation and endometrial cancer
Bianchi, F, Rosati, S, Belvederesi, L, Loretelli, C, Catalani, R, Mandolesi, A, Bracci, R, Bearzi, I, Porfiri, E, Cellerino, R
Published in International journal of gynecological cancer (01.05.2006)
Published in International journal of gynecological cancer (01.05.2006)
Get more information
Journal Article
Elderly Patients with advanced non-small cell lung cancer: A phase II study with weekly cisplatin and gemcitabine
BERARDI, R, PORFIRI, E, CELLERINO, R, SCARTOZZI, M, LIPPE, P, SILVA, R. R, NACCIARRITI, D, MENICHETTI, E. T, TUMMARELLO, D, CARLE, F, PIGA, A
Published in Oncology (01.01.2003)
Published in Oncology (01.01.2003)
Get full text
Journal Article
MSH2 splice site mutation and endometrial cancer
Bianchi, F, Rosati, S, Belvederesi, L, Loretelli, C, Catalani, R, Mandolesi, A, Bracci, R, Bearzi, I, Porfiri, E, Cellerino, R
Published in International journal of gynecological cancer (01.04.2006)
Published in International journal of gynecological cancer (01.04.2006)
Get full text
Journal Article
Beta-catenin gene analysis in oral squamous cell carcinoma
Lo Muzio, L, Goteri, G, Capretti, R, Rubini, C, Vinella, A, Fumarulo, R, Bianchi, F, Mastrangelo, F, Porfiri, E, Mariggiò, M A
Published in International journal of immunopathology and pharmacology (01.07.2005)
Get full text
Published in International journal of immunopathology and pharmacology (01.07.2005)
Journal Article
49LBA Final results of a Phase II randomised study of cediranib (RECENTIN™) in patients with advanced renal cell carcinoma (RCC)
Mulders, P, Hawkins, R, Nathan, P, de Jong, I, Osanto, S, Porfiri, E, Protheroe, A, Mookerjee, B, Pike, L, Gore, M.E
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase II study
Lippe, P., Tummarello, D., Monterubbianesi, M. C., Silva, R. R., Giuliodori, L., Mari, D., Santo, A., Pasini, F., Cetto, G. L., Rossi, D., Porfiri, E., Cascinu, S., Cellerino, R.
Published in Annals of oncology (01.02.1999)
Published in Annals of oncology (01.02.1999)
Get full text
Journal Article